Software Open Access
The objective of McMarcel is to evaluate the impact and cost-effectiveness of potential maternal and neonatal RSV immunisation strategies in 72 Gavi countries. The acronym stands for Multi-Country Model Application for RSV Cost-Effectiveness poLicy (McMarcel).
If you use (parts of) this modelling project, please cite: Li, Willem, Antillon, Bilcke, Jit, Beutels. Health and economic burden of Respiratory Syncytial Virus (RSV) disease and the cost-effectiveness of potential interventions against RSV among children under 5 years in 72 Gavi-eligible countries. BMC Medicine. (2020) [under review]